Pirisudanol

Pirisudanol

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	N06BX08 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 2-(dimethylamino)ethyl[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridinyl]methylbutanedioate
CAS Number	33605-94-6 Y
PubChem CID	65782
ChemSpider	59202
UNII	W618Z2SMVL
KEGG	D07347 Y
CompTox Dashboard (EPA)	DTXSID60187301
ECHA InfoCard	100.046.887
Chemical and physical data
Formula	C16H24N2O6
Molar mass	340.376 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1=NC=C(C(=C1O)CO)COC(=O)CCC(=O)OCCN(C)C
InChI InChI=1S/C16H24N2O6/c1-11-16(22)13(9-19)12(8-17-11)10-24-15(21)5-4-14(20)23-7-6-18(2)3/h8,19,22H,4-7,9-10H2,1-3H3 Key:KTOAWCPDBUCJED-UHFFFAOYSA-N
(verify)

Pirisudanol (Mentis, Menthen, Mentium, Nadex, Nadexen, Nadexon, Pridana, Stivane), also known as pyrisuccideanol, is the succinic acid ester of pyridoxine (a form of vitamin B₆) and of deanol (DMAE). It has been used in Europe in the treatment of mild cognitive impairment as well as fatigue and depression.

See also

• Pyritinol